News
Under terms of the deal, both companies will co-develop and co-commercialize BNT327 for multiple solid tumors, with the ...
5h
Investor's Business Daily on MSNDow Jones Falls On U.S.-China Tensions; Palantir, Nucor Are Early WinnersThe Dow Jones fell modestly Monday amid U.S.-China tensions. Palantir and Tesla moved near buy points. Nucor jumped on Trump tariffs.
Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results